Literature DB >> 34606252

A Third Generation Potentially Bifunctional Trithiol Chelate, Its nat,1XXSb(III) Complex, and Selective Chelation of Radioantimony (119Sb) from Its Sn Target.

Aeli P Olson1, Li Ma2, Yutian Feng3, Firouzeh Najafi Khosroshahi2, Steven P Kelley2, Eduardo Aluicio-Sarduy1, Todd E Barnhart1, Heather M Hennkens2,4, Paul A Ellison1, Silvia S Jurisson2, Jonathan W Engle1,5.   

Abstract

The therapeutic potential of the Meitner-Auger- and conversion-electron emitting radionuclide 119Sb remains unexplored because of the difficulty of incorporating it into biologically targeted compounds. To address this challenge, we report the development of 119Sb production from electroplated tin cyclotron targets and its complexation by a novel trithiol chelate. The chelation reaction occurs in harsh solvent conditions even in the presence of large quantities of tin, which are necessary for production on small, low energy (16 MeV) cyclotrons. The 119Sb-trithiol complex has high stability and can be purified by HPLC. The third generation trithiol chelate and the analogous stable natSb-trithiol compound were synthesized and characterized, including by single-crystal X-ray diffraction analyses.

Entities:  

Year:  2021        PMID: 34606252      PMCID: PMC8800004          DOI: 10.1021/acs.inorgchem.1c01690

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  31 in total

1.  Medium to large scale radioisotope production for targeted radiotherapy using a small PET cyclotron.

Authors:  H Thisgaard; M Jensen; D R Elema
Journal:  Appl Radiat Isot       Date:  2010-08-04       Impact factor: 1.513

Review 2.  Drug resistance in leishmaniasis.

Authors:  Simon L Croft; Shyam Sundar; Alan H Fairlamb
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  PLATON SQUEEZE: a tool for the calculation of the disordered solvent contribution to the calculated structure factors.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

4.  Monte Carlo Evaluation of Auger Electron-Emitting Theranostic Radionuclides.

Authors:  Nadia Falzone; José M Fernández-Varea; Glenn Flux; Katherine A Vallis
Journal:  J Nucl Med       Date:  2015-07-23       Impact factor: 10.057

5.  Fast Monte Carlo simulation of DNA damage induction by Auger-electron emission.

Authors:  Ya-Yun Hsiao; Tzu-Hsiang Hung; Shu-Ju Tu; Chuan-Jong Tung
Journal:  Int J Radiat Biol       Date:  2014-03-12       Impact factor: 2.694

6.  The production of 177-Sb-labelled potassium antimonyl tartrate for medical use.

Authors:  M L Thakur; J C Clark; D J Silvester
Journal:  Int J Appl Radiat Isot       Date:  1970-01

7.  Production of the Auger emitter 119Sb for targeted radionuclide therapy using a small PET-cyclotron.

Authors:  H Thisgaard; M Jensen
Journal:  Appl Radiat Isot       Date:  2008-09-17       Impact factor: 1.513

8.  First-in-Humans Application of 161Tb: A Feasibility Study Using 161Tb-DOTATOC.

Authors:  Richard P Baum; Aviral Singh; Harshad R Kulkarni; Peter Bernhardt; Tobias Rydén; Christiane Schuchardt; Nadezda Gracheva; Pascal V Grundler; Ulli Köster; Dirk Müller; Michael Pröhl; Jan Rijn Zeevaart; Roger Schibli; Nicholas P van der Meulen; Cristina Müller
Journal:  J Nucl Med       Date:  2021-02-05       Impact factor: 10.057

9.  Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancer.

Authors:  Colette J Shen; Il Minn; Robert F Hobbs; Ying Chen; Anders Josefsson; Mary Brummet; Sangeeta R Banerjee; Cory F Brayton; Ronnie C Mease; Martin G Pomper; Ana P Kiess
Journal:  Theranostics       Date:  2020-02-03       Impact factor: 11.556

Review 10.  Auger electrons for cancer therapy - a review.

Authors:  Anthony Ku; Valerie J Facca; Zhongli Cai; Raymond M Reilly
Journal:  EJNMMI Radiopharm Chem       Date:  2019-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.